MedTrace Logo

Acute Pain Caused by Paclitaxel in Patients With Cancer

NCT00860041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2016-07-14

No results posted yet for this study

Summary

RATIONALE: Gathering information over time from patients receiving paclitaxel for cancer may help doctors learn more about pain caused by paclitaxel and plan the best treatment.

PURPOSE: This clinical trial is studying acute pain caused by paclitaxel in patients with cancer.

Conditions

  • Chemotherapeutic Agent Toxicity
  • Neurotoxicity
  • Pain
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BEHAVIORAL

pain questionnaires

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Charles L. Loprinzi, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-04-30
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00860041 on ClinicalTrials.gov